WASHINGTON (AP) — Fitness officialswill make COVID-19 vaccines more like the annual flu vaccine.
The Food and Drug Administration on Monday proposed a simplified approach to long-term vaccination efforts, allowing up to adults and children to be vaccinated once a year instead of the mutant virus.
This means Americans would no longer have to keep track of how many shots they’ve won or how many months have passed since their last retirement.
The proposal comes at a time when reinforcements are hard to sell. While more than 80% of the U. S. population is still in the U. S. population. If the U. S. government got at least one dose of the vaccine, only 16% of other eligible people got the last legal reinforcements in August.
The FDA will ask its panel of outside vaccine experts to participate in an assembly on Thursday. The company deserves its recommendation when determining long-term vaccine requirements for manufacturers.
In documents published online, FDA scientists say many Americans now have “sufficient pre-existing immunity” to the coronavirus due to vaccination, infection, or a combination of both. strains and make COVID-19 vaccines more like the annual flu vaccine, according to the agency.
For adults with weakened immune systems and very young children, a two-dose mixture may be needed to protect themselves. Scientists at the FDA and vaccine corporations would evaluate vaccination, infection rates, and other data to determine who deserves to get a single shot instead of a vaccine. Two-dose series.
The FDA will also ask its panel to vote on whether all vaccines target the same strains. This step would be mandatory to make the injections interchangeable, eliminating the existing complex formula of number one vaccines and boosters.
The first shots from Pfizer and Moderna, called the main series, point to the strain of the virus that first made the impression in 2020 and temporarily swept the world. Updated reinforcements introduced last fall were also changed to target omicron parents who had been dominant.
Under the FDA’s proposal, the agency, independent experts and brands would choose strains to target each year in early summer, leaving several months to produce and publish updated plans before the fall. This is the same technique that has been used for a long time. to choose strains for the annual flu vaccine.
Ultimately, FDA officials say moving to an annual program would make it less difficult to announce long-term vaccination campaigns, which could ultimately increase vaccination rates nationwide.